Product Description
Mechanisms of Action: N/A
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: N/A
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: Brazil | China | Pakistan | Russia | Taiwan | Ukraine
Approved Indications: None
Known Adverse Events: None
Company: Ineye Hospital of Chengdu University of Traditional Chinese Medicine
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| ChiCTR2300077773 | N/A |
Not yet recruiting |
Myopia |
2024-06-01 |
|
| ChiCTR2500096603 | N/A |
/Completed |
Myopia |
2023-09-30 |